SubsidieMeestersAccelerating the iMpact of microsurgEry by upscaling production of thE world’s first microsurgical roboT: MUSA
Microsure is launching MUSA, the first CE-certified microsurgical robot, to enhance precision and efficiency in microsurgery, aiming for widespread European adoption by 2029.
Projectdetails
Introduction
The revolution in microsurgery is here. Microsure, a highly innovative Dutch medical device company, is introducing MUSA, the world’s first clinically available CE-certified microsurgical robot.
Objectives
We will maximize microsurgical performance by offering superhuman precision and comfort through robotic assistance in pursuit of excellence for both patients and health providers.
Efficiency and Cost Reduction
The MUSA robot is highly efficient, thereby reducing costs and improving access to microsurgical procedures.
Market Readiness
With the great unmet need in microsurgery, we are convinced that the timing for market introduction of MUSA is right and the field is ready to accept and implement MUSA for better patient outcomes.
Project Goals
In this project, we will tackle the remaining bottlenecks for successful rollout of the product, including:
- Upscaling
- Optimizing manufacturability
This will allow for rapid market uptake of MUSA after the project.
Future Plans
MicroSure will introduce MUSA in all parts of Europe before 2029, reaching major societal and economic impact.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 1.814.022 |
| Totale projectbegroting | € 2.637.708 |
Tijdlijn
| Startdatum | 1-1-2022 |
| Einddatum | 30-4-2024 |
| Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- MICROSURE BVpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Next-generation surgical robotics to set a new standard of care in orthopaedic surgeryGanymed is developing an innovative surgical robot that enhances precision and safety in joint-replacement procedures through computer vision and data-driven insights for orthopaedic surgery. | EIC Accelerator | € 2.485.995 | 2022 | Details |
Transforming everyday surgery into a painless and scarless experienceThe M.I.L.A.N.O. Robotic Platform offers a versatile, portable surgical solution that enables quick setup for various minimally invasive procedures, enhancing patient access and safety. | EIC Accelerator | € 2.499.999 | 2023 | Details |
Multi4 - the first surgical instrument for bladder cancer treatment through a 20-minute outpatient procedureMulti4 is developing an innovative surgical instrument for bladder cancer treatment that enables outpatient procedures, enhancing patient care and reducing recurrence rates. | EIC Accelerator | € 2.493.000 | 2024 | Details |
Assistive Medical Robotics for Very Early Mobilization of Critical Care PatientsVEMOTION is an AI-driven robotic system designed to safely implement early mobilisation in ICUs, enhancing patient recovery, reducing costs, and expanding ICU capacity, supported by a €2.5M EIC grant. | EIC Accelerator | € 2.490.337 | 2023 | Details |
Next-generation surgical robotics to set a new standard of care in orthopaedic surgery
Ganymed is developing an innovative surgical robot that enhances precision and safety in joint-replacement procedures through computer vision and data-driven insights for orthopaedic surgery.
Transforming everyday surgery into a painless and scarless experience
The M.I.L.A.N.O. Robotic Platform offers a versatile, portable surgical solution that enables quick setup for various minimally invasive procedures, enhancing patient access and safety.
Multi4 - the first surgical instrument for bladder cancer treatment through a 20-minute outpatient procedure
Multi4 is developing an innovative surgical instrument for bladder cancer treatment that enables outpatient procedures, enhancing patient care and reducing recurrence rates.
Assistive Medical Robotics for Very Early Mobilization of Critical Care Patients
VEMOTION is an AI-driven robotic system designed to safely implement early mobilisation in ICUs, enhancing patient recovery, reducing costs, and expanding ICU capacity, supported by a €2.5M EIC grant.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Implantable microroBOTThe I-BOT project aims to develop advanced implantable microrobots with multimodal locomotion and shape memory capabilities for precise medical applications like ulcer filling and tumor monitoring. | ERC Starting... | € 1.497.923 | 2025 | Details |
AI and Robotics for Prostate BiopsyThe ROBIOPSY project aims to develop a robotic prostate biopsy prototype for clinical trials, enhancing diagnostic accuracy and addressing health economics for improved cancer treatment. | EIC Transition | € 2.499.141 | 2023 | Details |
MusculoSkeletal ExpansionMUSE aims to develop innovative soft exomuscles for individuals with severe muscle weakness, enhancing daily living through osseointegration and sensory feedback for improved control and efficiency. | ERC Starting... | € 1.499.160 | 2024 | Details |
Stuurbare instrumenten voor arthroscopie en laparoscopieOntwikkeling van innovatieve chirurgische instrumenten voor minimaal invasieve operaties met een nieuwe aansturingstechniek, gericht op verbeterde workflow en patiëntveiligheid. | Mkb-innovati... | € 102.543 | 2017 | Details |
SURgical eNhanced Image Augmented Reality (SURNIA)SURNIA ontwikkelt een innovatieve chirurgische loep met augmented reality voor verbeterde precisie, training en real-time ondersteuning in operaties. | Mkb-innovati... | € 198.065 | 2020 | Details |
Implantable microroBOT
The I-BOT project aims to develop advanced implantable microrobots with multimodal locomotion and shape memory capabilities for precise medical applications like ulcer filling and tumor monitoring.
AI and Robotics for Prostate Biopsy
The ROBIOPSY project aims to develop a robotic prostate biopsy prototype for clinical trials, enhancing diagnostic accuracy and addressing health economics for improved cancer treatment.
MusculoSkeletal Expansion
MUSE aims to develop innovative soft exomuscles for individuals with severe muscle weakness, enhancing daily living through osseointegration and sensory feedback for improved control and efficiency.
Stuurbare instrumenten voor arthroscopie en laparoscopie
Ontwikkeling van innovatieve chirurgische instrumenten voor minimaal invasieve operaties met een nieuwe aansturingstechniek, gericht op verbeterde workflow en patiëntveiligheid.
SURgical eNhanced Image Augmented Reality (SURNIA)
SURNIA ontwikkelt een innovatieve chirurgische loep met augmented reality voor verbeterde precisie, training en real-time ondersteuning in operaties.